Skip to main content
letter
. 2024 Dec 18;28:409. doi: 10.1186/s13054-024-05191-9

Fig. 1.

Fig. 1

Association of baricitinib therapy on 30-day mortality according to total parenteral nutrition. Odds ratios (represented by squares) and 95% CIs (corresponding lines through them) were calculated for the propensity score-matched baricitinib (n = 557) and tocilizumab (n = 557) groups. a p values are for the interaction term. CI confidence interval